Complete Wegovy vs Mounjaro Dosage Comparison Guide
Wegovy vs Mounjaro Dosage: Complete Treatment Journey Mapping
Understanding the Wegovy vs Mounjaro dosage landscape requires examining two fundamentally different treatment pathways. Wegovy (semaglutide) follows a structured 16-week escalation from 0.25mg to maintenance 2.4mg, whilst Mounjaro (tirzepatide) uses the same starting dose but escalates differently due to its dual GIP and GLP-1 receptor mechanism. At EverydayMeds, we maintain complete stock levels of every Wegovy dose, ensuring patients can progress seamlessly without supply interruptions that plague other pharmacies.
The critical difference in Wegovy vs Mounjaro dosage planning lies in their titration flexibility and maintenance requirements. Wegovy's escalation is clinically standardised—4 weeks each at 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching 2.4mg maintenance. This predictable schedule allows patients to plan their entire treatment journey, knowing exactly when they'll need each dose and what it will cost. Our Complete Journey bundles reflect this structured approach, providing Reliable Supply continuity that eliminates the anxiety of dose availability.
Wegovy vs Mounjaro Dosage Pricing: Transparent Cost Comparison
Wegovy pricing at EverydayMeds reflects our commitment to transparent, competitive rates across every dose level. Single pens start at £79.99 for 0.25mg (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for maintenance 2.4mg. Our Getting Started bundles provide convenient dual-dose packages—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25.
When comparing Wegovy vs Mounjaro dosage costs, the economic advantage becomes clear through our bundle offerings. The Intro Trio (0.25mg, 0.5mg & 1mg) provides 12 weeks of treatment for £299.99, covering the critical initial phase where patients establish tolerance and begin seeing results. For those reaching maintenance, our Ultimate Stability Trio delivers three months of 2.4mg supply for £649.99, providing security and convenience for long-term weight management commitment.
Clinical Evidence: Wegovy vs Mounjaro Dosage Efficacy Data
The STEP trial programme demonstrates Wegovy's efficacy across its dosage range, with the 2.4mg maintenance dose showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise. The SELECT cardiovascular outcomes trial further validated Wegovy's 2.4mg dose with a 20% reduction in major cardiovascular events. These results establish the clinical rationale for Wegovy's specific dosing schedule.
When examining Wegovy vs Mounjaro dosage effectiveness, both treatments have demonstrated significant weight management benefits in their respective trial programmes, though direct comparisons aren't appropriate due to different study designs and populations. The structured Wegovy escalation to 2.4mg represents a clinically optimised balance between efficacy and tolerability, developed through extensive phase III testing across diverse patient populations.
Mechanism of Action: How Wegovy Dosage Levels Work
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. The gradual dose escalation from 0.25mg to 2.4mg allows patients' systems to adapt to increased GLP-1 receptor activation, minimising gastrointestinal side effects whilst maximising therapeutic benefit. Each dose level provides progressively stronger appetite suppression and enhanced satiety signalling between the gut and brain. The 2.4mg maintenance dose represents the optimal balance for sustained weight management, providing sufficient GLP-1 receptor engagement for long-term appetite control. This prescription-only medicine requires careful monitoring throughout the escalation process to ensure both safety and effectiveness.
EverydayMeds Ordering Process: Streamlined Wegovy Access
Accessing Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture essential medical history and current health status. Our prescribers review applications within 3 working days as standard, or within 24 hours using our express service for faster treatment initiation. Once approved, your chosen Wegovy dose ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication stability. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and professional pharmaceutical oversight throughout your treatment journey. The entire process, from assessment to delivery, typically completes within 4-5 days, getting patients started on their weight management programme without unnecessary delays.
Storage and Practical Considerations: Wegovy vs Mounjaro Dosage Differences
Wegovy offers significant practical advantages in storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. The FlexTouch pen design provides intuitive dose administration with clear dosage confirmation and safety features. Each pen contains exactly 4 weekly doses, with the escalation schedule requiring a new pen strength every month during titration. Patients must store unopened pens in the refrigerator at 2-8°C and can keep their current pen at room temperature for convenient daily access. This storage advantage makes Wegovy particularly suitable for patients with active lifestyles, travel requirements, or limited refrigerator space. The prescription-only medicine status requires proper handling and disposal through pharmaceutical waste programmes.
Complete Dose Range Strategy: Why EverydayMeds Stocks Everything
EverydayMeds' commitment to stocking every Wegovy dose reflects our understanding that weight management is a long-term journey requiring consistent supply security. Unlike pharmacies that experience frequent stock shortages, particularly of starter and maintenance doses, our inventory management prioritises treatment continuity above profit margins. Patients beginning their Wegovy vs Mounjaro dosage comparison can feel confident that choosing Wegovy through EverydayMeds means never facing supply interruptions that could derail progress.
This comprehensive approach extends to our bundle offerings, designed around real-world prescribing patterns rather than arbitrary combinations. The Take-It-Slow bundles acknowledge that some patients need extended time at lower doses, whilst our Step-Up bundles facilitate smooth progression for those tolerating escalation well. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment and dosing approach aligns best with your individual circumstances and weight management goals.
Start Your Weight Management Journey: Wegovy vs Mounjaro Dosage Decision
Making the Wegovy vs Mounjaro dosage choice becomes straightforward with EverydayMeds' comprehensive support and transparent pricing structure. Our clinical assessment process helps identify the most suitable treatment option based on your medical history, lifestyle factors, and weight management objectives. New customers can begin with our Intro Duo bundle at £169.99 using code FIRST40, providing the first 8 weeks of treatment with assured next-dose availability. Returning customers benefit from DOSE25 pricing across our complete range, ensuring long-term affordability throughout their maintenance phase. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and secure your complete treatment supply today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
